Skip to content

Vancomycin induced acute kidney injury: a multi-center, retrospective-prospective, observational, cohort study

Vancomycin induced acute kidney injury: a multi-center, retrospective-prospective, observational, cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094474
Enrollment
Unknown
Registered
2024-12-23
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute kindey injury

Interventions

Observation group:None

Sponsors

Zhongshan Hospital Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients on vancomycin for anti-infective therapy. 2. Combined use of compound glycyrrhizin preparations during vancomycin treatment. Compound glycyrrhizin preparations include glycyrrhizinate diamine enteric-coated tablets, glycyrrhizinate diamine enteric-coated capsules, compound monoammonium glycyrrhizinate S injection, glycyrrhizinate monoammonium cysteine sodium chloride injection, compound glycyrrhizin capsules, compound glycyrrhizinate injection, and magnesium isoglycyrrhizinate injection. 3. Vancomycin and compound glycyrrhizin preparations are used simultaneously for more than 48 hours.

Exclusion criteria

Exclusion criteria: 1. Chronic kidney disease stage 5 or regular dialysis, 2. Kidney transplant status or solitary kidney, 3. Non-intravenous vancomycin, 4. Insufficient measurement of serum creatinine (SCr).

Design outcomes

Primary

MeasureTime frame
Serum creatinine;

Countries

China

Contacts

Public ContactKunming Pan

Zhongshan Hospital Fudan University

panxso@163.com+86 150 2662 9516

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 9, 2026